RxSight, Inc. (RXST) Deep Dive Video

Summary

A monopoly-grade cataract innovation with ~80% gross margins—and a broken go-to-market—trading near its cash floor as investors wager on a utilization turnaround or strategic takeout.

View RXST stock page · Read the RXST research report

Loading the video player…